Interestingly, an increased risk of ovarian cancer is not associated with Li-Fraumeni syndrome (where TP53 mutations are characteristic), especially considering that p53 signatures foci in distal fallopian tube are much more numerous in patients with Li-Fraumeni syndrome [69]. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.